Por favor, use este identificador para citar o enlazar a este item:
http://hdl.handle.net/10261/306445
COMPARTIR / EXPORTAR:
SHARE CORE BASE | |
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE | |
Título: | Inhibition of ATG3 ameliorates liver steatosis by increasing mitochondrial function |
Autor: | Lima, Natália da Silva; Fondevila, Marcos F.; Nóvoa, Eva; Buqué, Xabier; Mercado-Gómez, María; Gallet, Sarah; González-Rellán, María Jesús; Fernández, Uxía; Loyens, Anne; García-Vence, María; Chantada-Vázquez, María del Pilar; Bravo, Susana Belén; Marañón, Patricia; Senra, Ana; Escudero, Adriana; Leiva, Magdalena; Guallar, Diana; Fidalgo, Miguel; Gomes, Pedro; Claret, Marc; Sabio, Guadalupe CSIC ORCID; Varela-Rey, Marta; Delgado, Teresa C.; Montero-Vallejo, Rocío CSIC ORCID CVN; Ampuero, Javier CSIC ORCID; López, Miguel; Diéguez, Carlos; Herrero, Laura CSIC ORCID; Serra, Dolors; Schwaninger, Markus; Prevot, Vincent; Gallego-Durán, Rocío CSIC ORCID; Romero-Gómez, Manuel CSIC ORCID CVN; Iruzubieta, Paula; Crespo, Javier CSIC; Martínez-Chantar, María Luz CSIC ORCID; García-Monzón, Carmelo; González-Rodríguez, Águeda CSIC ORCID; Aspichueta, Patricia; Nogueiras, Rubén | Palabras clave: | ATG3 NAFLD NASH Lipid metabolism Mitochondria Sirtuin 1 |
Fecha de publicación: | ene-2022 | Editor: | Elsevier BV European Association for the Study of the Liver |
Citación: | Journal of Hepatology 76(1): 11-24 (2022) | Resumen: | [Background & Aims] Autophagy-related gene 3 (ATG3) is an enzyme mainly known for its actions in the LC3 lipidation process, which is essential for autophagy. Whether ATG3 plays a role in lipid metabolism or contributes to non-alcoholic fatty liver disease (NAFLD) remains unknown. [Methods] By performing proteomic analysis on livers from mice with genetic manipulation of hepatic p63, a regulator of fatty acid metabolism, we identified ATG3 as a new target downstream of p63. ATG3 was evaluated in liver samples from patients with NAFLD. Further, genetic manipulation of ATG3 was performed in human hepatocyte cell lines, primary hepatocytes and in the livers of mice. [Results] ATG3 expression is induced in the liver of animal models and patients with NAFLD (both steatosis and non-alcoholic steatohepatitis) compared with those without liver disease. Moreover, genetic knockdown of ATG3 in mice and human hepatocytes ameliorates p63- and diet-induced steatosis, while its overexpression increases the lipid load in hepatocytes. The inhibition of hepatic ATG3 improves fatty acid metabolism by reducing c-Jun N-terminal protein kinase 1 (JNK1), which increases sirtuin 1 (SIRT1), carnitine palmitoyltransferase 1a (CPT1a), and mitochondrial function. Hepatic knockdown of SIRT1 and CPT1a blunts the effects of ATG3 on mitochondrial activity. Unexpectedly, these effects are independent of an autophagic action. [Conclusions] Collectively, these findings indicate that ATG3 is a novel protein implicated in the development of steatosis. |
URI: | http://hdl.handle.net/10261/306445 | DOI: | 10.1016/j.jhep.2021.09.008 | ISSN: | 0168-8278 |
Aparece en las colecciones: | (IBIS) Artículos |
Ficheros en este ítem:
Fichero | Descripción | Tamaño | Formato | |
---|---|---|---|---|
Inhibition_ATG3_Silva_Lima.pdf | 4,55 MB | Adobe PDF | Visualizar/Abrir |
CORE Recommender
PubMed Central
Citations
9
checked on 28-abr-2024
SCOPUSTM
Citations
19
checked on 19-abr-2024
WEB OF SCIENCETM
Citations
15
checked on 22-feb-2024
Page view(s)
57
checked on 28-abr-2024
Download(s)
19
checked on 28-abr-2024